Literature DB >> 26150428

Smoking is associated with aggravated kidney injury in Puumala hantavirus-induced haemorrhagic fever with renal syndrome.

Laura Tervo1, Satu Mäkelä2, Jaana Syrjänen2, Reetta Huttunen1, Arja Rimpelä3, Heini Huhtala4, Olli Vapalahti5, Antti Vaheri5, Jukka Mustonen2.   

Abstract

BACKGROUND: Previous studies indicate that smoking affects the outcome of some infections and is a risk factor for Puumala virus (PUUV) infection. The aim of this study was to assess the effect of smoking on the clinical severity of PUUV infection and the prevalence of smoking in patients with PUUV infection.
METHODS: A questionnaire on smoking habits was sent to 494 patients in 2012, who had been treated in Tampere University Hospital, Finland, for serologically confirmed PUUV infection during years 1982-2012.
RESULTS: Of all patients, 357 (72%) participated. Maximum plasma creatinine level measured during acute illness was significantly higher in current smokers than in non-smokers (median: 273 versus 184 µmol/L, P < 0.001). Current smokers had a higher maximum blood leucocyte count than non-smokers (median: 10.8 versus 8.9 × 10(9)/L, P < 0.001) and they were younger than non-smokers (38 versus 45 years, P < 0.001). There were no differences between current smokers and non-smokers in the other variables reflecting the severity of PUUV infection. Altogether 51% were current smokers at the time of onset of the illness, 57% of males and 36% of females. During these years in Finland, smoking among males in the same aged population has decreased from 33 to 22% and among females, smoking has varied between 14 and 20%.
CONCLUSIONS: Smoking is common in patients with PUUV infection. Current smokers suffer from more severe acute kidney injury (AKI) and they have higher leucocyte count than non-smokers in PUUV infection. Smoking cessation decreases the risk of severe AKI to the same level as observed in never-smokers.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  Puumala virus; acute kidney injury; acute tubulointerstitial nephritis; hantavirus infection; smoking

Mesh:

Year:  2015        PMID: 26150428      PMCID: PMC4838005          DOI: 10.1093/ndt/gfv273

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

1.  A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk?

Authors:  F Van Loock; I Thomas; J Clement; S Ghoos; P Colson
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

2.  Smoking and the kidney.

Authors:  Stephan R Orth
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

3.  KDIGO clinical practice guidelines for acute kidney injury.

Authors:  Arif Khwaja
Journal:  Nephron Clin Pract       Date:  2012-08-07

4.  Hemorrhagic Fever with Renal Syndrome in the New, and Hantavirus Pulmonary Syndrome in the Old World: paradi(se)gm lost or regained?

Authors:  Jan Clement; Piet Maes; Marc Van Ranst
Journal:  Virus Res       Date:  2014-01-17       Impact factor: 3.303

5.  Epidemiological study of nephropathia epidemica in Finland 1989-96.

Authors:  M Brummer-Korvenkontio; O Vapalahti; H Henttonen; P Koskela; P Kuusisto; A Vaheri
Journal:  Scand J Infect Dis       Date:  1999

6.  Validation of self reported smoking by serum cotinine measurement in a community-based study.

Authors:  E Vartiainen; T Seppälä; P Lillsunde; P Puska
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

7.  Tobacco smoking increases the risk for death from pneumococcal pneumonia.

Authors:  Salvador Bello; Rosario Menéndez; Torres Antoni; Soledad Reyes; Rafael Zalacain; Alberto Capelastegui; Javier Aspa; Luis Borderías; Juan J Martin-Villasclaras; Immaculada Alfageme; Felipe Rodríguez de Castro; Jordi Rello; Molinos Luis; Juan Ruiz-Manzano
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

Review 8.  The renal risks of smoking: an update.

Authors:  Stephan R Orth; Eberhard Ritz
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-09       Impact factor: 2.894

9.  Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.

Authors:  Satu Mäkelä; Jukka Mustonen; Ilpo Ala-Houhala; Mikko Hurme; Jukka Partanen; Olli Vapalahti; Antti Vaheri; Amos Pasternack
Journal:  J Infect Dis       Date:  2002-08-16       Impact factor: 5.226

Review 10.  Hantavirus infections in Europe.

Authors:  Olli Vapalahti; Jukka Mustonen; Ake Lundkvist; Heikki Henttonen; Alexander Plyusnin; Antti Vaheri
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

View more
  13 in total

1.  Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of Chikungunya virus infection.

Authors:  Ivan Delgado-Enciso; Brenda Paz-Michel; Valery Melnikov; Jose Guzman-Esquivel; Francisco Espinoza-Gomez; Alejandro D Soriano-Hernandez; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Gabriel Ceja-Espiritu; Bertha A Olmedo-Buenrostro; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Josuel Delgado-Enciso; Uriel A Lopez-Lemus; Daniel A Montes-Galindo
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

Review 2.  Hantavirus infection: a global zoonotic challenge.

Authors:  Hong Jiang; Xuyang Zheng; Limei Wang; Hong Du; Pingzhong Wang; Xuefan Bai
Journal:  Virol Sin       Date:  2017-01-23       Impact factor: 4.327

3.  Acute hantavirus infection presenting as haemolytic-uraemic syndrome (HUS): the importance of early clinical diagnosis.

Authors:  J Clement; A P K Lee; G A Verpooten; L Laenen; V Vergote; H De Samblanx; Z N Berneman; M Van Ranst; P Maes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-06       Impact factor: 3.267

4.  Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor.

Authors:  F Latronico; S Mäki; H Rissanen; J Ollgren; O Lyytikäinen; O Vapalahti; J Sane
Journal:  Epidemiol Infect       Date:  2018-01-09       Impact factor: 4.434

5.  An outbreak of haemorrhagic fever with renal syndrome linked with mountain recreational activities in Zagreb, Croatia, 2017.

Authors:  Z Lovrić; B Kolarić; M L Kosanović Ličina; M Tomljenović; O Đaković Rode; K Danis; B Kaić; V Tešić
Journal:  Epidemiol Infect       Date:  2018-05-16       Impact factor: 4.434

6.  Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi.

Authors:  Ellen Krautkrämer; Christian Nusshag; Alexandra Baumann; Julia Schäfer; Jörg Hofmann; Paul Schnitzler; Boris Klempa; Peter T Witkowski; Detlev H Krüger; Martin Zeier
Journal:  BMC Infect Dis       Date:  2016-11-14       Impact factor: 3.090

7.  Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection.

Authors:  Tuula K Outinen; Paula Mantula; Pia Jaatinen; Mari Hämäläinen; Eeva Moilanen; Antti Vaheri; Heini Huhtala; Satu Mäkelä; Jukka Mustonen
Journal:  Viruses       Date:  2019-08-21       Impact factor: 5.048

Review 8.  Hantavirus Research in Finland: Highlights and Perspectives.

Authors:  Antti Vaheri; Heikki Henttonen; Jukka Mustonen
Journal:  Viruses       Date:  2021-07-26       Impact factor: 5.048

9.  Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.

Authors:  Maxime Hentzien; Stéphanie Mestrallet; Pascale Halin; Laure-Anne Pannet; Delphine Lebrun; Moustapha Dramé; Firouzé Bani-Sadr; Jean-Marc Galempoix; Christophe Strady; Jean-Marc Reynes; Christian Penalba; Amélie Servettaz
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

10.  Flash-Like Albuminuria in Acute Kidney Injury Caused by Puumala Hantavirus Infection.

Authors:  Paula Mantula; Johanna Tietäväinen; Jan Clement; Onni Niemelä; Ilkka Pörsti; Antti Vaheri; Jukka Mustonen; Satu Mäkelä; Tuula Outinen
Journal:  Pathogens       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.